A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality
- PMID: 37845006
- PMCID: PMC10667816
- DOI: 10.1002/advs.202305096
A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality
Abstract
Despite advances in precision oncology, cancer remains a global public health issue. In this report, proof-of-principle evidence is presented that a cell-penetrable peptide (ACP52C) dissociates transcription factor CP2c complexes and induces apoptosis in most CP2c oncogene-addicted cancer cells through transcription activity-independent mechanisms. CP2cs dissociated from complexes directly interact with and degrade YY1, leading to apoptosis via the MDM2-p53 pathway. The liberated CP2cs also inhibit TDP2, causing intrinsic genome-wide DNA strand breaks and subsequent catastrophic DNA damage responses. These two mechanisms are independent of cancer driver mutations but are hindered by high MDM2 p60 expression. However, resistance to ACP52C mediated by MDM2 p60 can be sensitized by CASP2 inhibition. Additionally, derivatives of ACP52C conjugated with fatty acid alone or with a CASP2 inhibiting peptide show improved pharmacokinetics and reduced cancer burden, even in ACP52C-resistant cancers. This study enhances the understanding of ACP52C-induced cancer-specific apoptosis induction and supports the use of ACP52C in anticancer drug development.
Keywords: CP2c complex disruption; a cell-penetrant peptide; pan-anticancer drug; synthetic lethality; transcription factor CP2c.
© 2023 The Authors. Advanced Science published by Wiley-VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10667816/bin/ADVS-10-2305096-g002.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10667816/bin/ADVS-10-2305096-g005.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10667816/bin/ADVS-10-2305096-g004.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10667816/bin/ADVS-10-2305096-g008.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10667816/bin/ADVS-10-2305096-g007.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10667816/bin/ADVS-10-2305096-g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10667816/bin/ADVS-10-2305096-g009.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10667816/bin/ADVS-10-2305096-g001.gif)
Similar articles
-
Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma.Oncotarget. 2017 Apr 11;8(15):24389-24400. doi: 10.18632/oncotarget.15462. Oncotarget. 2017. PMID: 28412749 Free PMC article.
-
SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression.Sci Adv. 2023 Jan 27;9(4):eadd4969. doi: 10.1126/sciadv.add4969. Epub 2023 Jan 27. Sci Adv. 2023. PMID: 36706181 Free PMC article.
-
Structural and Functional Insights into CP2c Transcription Factor Complexes.Int J Mol Sci. 2022 Jun 7;23(12):6369. doi: 10.3390/ijms23126369. Int J Mol Sci. 2022. PMID: 35742810 Free PMC article.
-
DNA Double Strand Break Repair - Related Synthetic Lethality.Curr Med Chem. 2019;26(8):1446-1482. doi: 10.2174/0929867325666180201114306. Curr Med Chem. 2019. PMID: 29421999 Review.
-
Transcription factors that interact with p53 and Mdm2.Int J Cancer. 2016 Apr 1;138(7):1577-85. doi: 10.1002/ijc.29663. Epub 2015 Jul 14. Int J Cancer. 2016. PMID: 26132471 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- NRF-2017M3A9C8027975/National Research Foundation of Korea, Bio & Medical Technology Development
- 2010-0025223/National Research Foundation of Korea, Basic Science Research Program
- 2014R1A2A1A11054432/National Research Foundation of Korea, Basic Science Research Program
- NRF-2020R1A2C2009112/National Research Foundation of Korea, Basic Science Research Program
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous